Fact Based List:
Sydney Rubin: Five Measures to Cope With The Pharmaceutical Side Effects Of Health Reform
Submitted by Anonymous on Thu, 10/09/2014 - 11:09
- Identify products that are potential targets for cost sharing, including new and specialty medicines
- Reach out to patient groups and high-profile patient bloggers to begin discussion on patient perspectives, wants and needs
- Provide clear and compelling educational materials to organizations that help demonstrate a medicine’s value
- Where ACA safeguards are insufficient, product suppliers should consider advocating for additional state or federal policy interventions
- Assume that external and internal communications are visible to payers and make sure all communications around a drug’s value are consistent and aligned
Source: Pharm Exec.
Source URL: http://blog.pharmexec.com/2014/10/03/coping-with-the-side-ef...
List Ratings: |
Lists You Might Also Be Interested In
- Fortune 500 Ranking of Major Pharmaceutical Companies by Rank, Including Revenue (in millions)
- KPMG: Ten Imperatives for Pharmaceutical Commercial Transformation
- Top Ten Countries with Highest Total Expenditure on Pharmaceuticals (% total expenditure on health)
- Projected Top Five pharmaceutical products worldwide by revenue in 2017 ($USD billions)
- 2012: Top 10 Pharmaceutical Companies Contributing to Federal Candidates, Parties, and Outside Groups
Login or register to post comments